[Five year follow-up of 104 cardial artery deobliteration (author's transl)]
Related Experiment Video
Updated: Aug 21, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Insights
Carotid endarteriectomy offers moderate long-term survival benefits, primarily by reducing neurological accidents. However, 5-year mortality remains significant, especially for advanced stages of internal carotid artery stenosis.
Area of Science:
- Vascular Surgery
- Neurology
- Cardiology
Context:
- Internal carotid artery stenosis affects numerous patients, posing risks of stroke and neurological deficits.
- Surgical intervention, specifically carotid endarteriectomy, has been a cornerstone treatment.
- Long-term outcomes and survival rates following this procedure require continued evaluation.
Purpose:
- To evaluate the 5-year outcomes, including mortality and recurrence rates, of patients who underwent carotid endarteriectomy.
- To assess the impact of disease severity (staging) on patient survival and procedural success.
- To determine the long-term survival benefits and neurological protection offered by carotid endarteriectomy.
Summary:
- A 5-year reevaluation of 104 patients who underwent carotid endarteriectomy for internal carotid artery stenosis between 1964 and 1972.
- Overall 5-year mortality was 34%, with survival rates decreasing from 87% in the first year.
- Mortality differed significantly by disease stage (19% for stages 0, I, mild-III vs. 67% for others). Local recurrence was low (3%).
Impact:
- Carotid endarteriectomy demonstrates a clear benefit in reducing neurological accidents.
- Long-term survival improvement is moderate, influenced by comorbid conditions like coronary disease.
- The procedure's effectiveness is strongly dependent on the stage of internal carotid artery stenosis at the time of surgery.
Abstract:
From December 1, 1964 to December 31, 1977, 613 patients underwent 699 operations for stenotic lesions of the internal carotid artery. One hundred and four of these cases, operated before December 31, 1972, were reevaluated at 5 years. These include 9 patients stage 0 (asymptomatic), 45 patients stage I (transitory), 8 patients stage II (progressive), 22 stage III mild (mild deficiencies), and 20 stage III severe (severe deficiencies). The overall 5 year mortality is 34% with a survival rate of 65%, steadily decreasing from 87% in the first year. There is a fundamental difference to be made between results in stages 0, I, mild-III and the other, for immediate and for 5 year mortality: 19% versus 67%. The rate of local recurrences is low: 3% of patients operated on the same side. In contrast, 11 subjects underwent a bilateral procedure. Carotidal endarteriectomy improves long term survival only moderately, mainly as a result of coronary disease. However it has an undisputable effect in diminishing neurological accidents.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care